Item 16. Form 10-K Summary

Not applicable.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.



	Signature	PERKINELMER, INC. Title	Date


By:	/S/ ROBERT F. FRIEL	Chairman, Chief Executive Officer	February 27, 2018
	Robert F. Friel	and President (Principal Executive Officer)

By:	/S/ FRANK A. WILSON	Sr. Vice President and	February 27, 2018
	Frank A. Wilson	Chief Financial Officer (Principal Financial Officer)

By:	/S/ ANDREW OKUN	Vice President and	February 27, 2018
	Andrew Okun	Chief Accounting Officer (Principal Accounting Officer)

POWER OF ATTORNEY AND SIGNATURES

We, the undersigned officers and directors of PerkinElmer, Inc., hereby severally constitute Robert F. Friel and Frank A. Wilson, and each of them singly, our true and lawful attorneys with full power to them, and each of them singly, to sign for us and in our names, in the capacities indicated below, this Annual Report on Form 10-K and any and all amendments to said Annual Report on Form 10-K, and generally to do all such things in our name and behalf in our capacities as officers and directors to enable PerkinElmer, Inc. to comply with the provisions of the Securities Exchange Act of 1934, and all requirements of the Securities and Exchange Commission, hereby rectifying and confirming signed by our said attorneys, and any and all amendments thereto.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:



	Signature	Title	Date


By:	/S/ ROBERT F. FRIEL	Chairman, Chief Executive Officer	February 27, 2018
	Robert F. Friel	and President (Principal Executive Officer)

By:	/S/ FRANK A. WILSON	Sr. Vice President and	February 27, 2018
	Frank A. Wilson	Chief Financial Officer (Principal Financial Officer)

By:	/S/ ANDREW OKUN	Vice President and	February 27, 2018
	Andrew Okun	Chief Accounting Officer (Principal Accounting Officer)

By:	/S/ PETER BARRETT	Director	February 27, 2018
	Peter Barrett

By:	/S/ SAMUEL R. CHAPIN	Director	February 27, 2018
	Samuel R. Chapin

By:	/S/ SYLVIE GRÉGOIRE, PharmD	Director	February 27, 2018
	Sylvie Grégoire, PharmD

By:	/S/ NICHOLAS A. LOPARDO	Director	February 27, 2018
	Nicholas A. Lopardo

By:	/S/ ALEXIS P. MICHAS	Director	February 27, 2018
	Alexis P. Michas

By:	/S/ PATRICK J. SULLIVAN	Director	February 27, 2018
	Patrick J. Sullivan

By:	/S/ FRANK WITNEY, PhD	Director	February 27, 2018
	Frank Witney, PhD

By:	/S/ PASCALE WITZ	Director	February 27, 2018
	Pascale Witz

Previous: Item 15. Exhibits and Financial Statement Schedules